Hepatitis C Care: Comparison of Monitoring Methods
A study analyzing US health data suggests that combining laboratory and pharmacy records provides the most accurate assessment of Hepatitis C treatment outcomes. The research highlights that relying on single data sources may lead to underestimating cure rates.
COMBINING laboratory and pharmacy data provided the most rigorous measure of hepatitis C care outcomes in a US cohort study, although incomplete follow-up RNA testing meant this approach could underestimate cure. When only one data source was available, laboratory-confirmed viral clearance or pharmacy-recorded treatment initiation could serve as reasonable surrogate measures of viral clearance after treatment initiation.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in